← FDA DRUG APPROVALS

FDA NDA · NDA018470

CIBACALCIN

Sponsor: NOVARTIS

APPLICATION
NDA018470
TYPE
NDA
ORIGINAL APPROVAL
1986-10-31
LATEST ACTION
1997-11-17
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CIBACALCINDiscontinued
CALCITONIN HUMAN 0.5MG/VIAL · INJECTABLE · INJECTION

Approval history

1997-11-17Labeling · Supplement 5AP
1995-12-18Labeling · Supplement 8 · standardAP
1989-03-06Labeling · Supplement 4AP
1987-06-29Labeling · Supplement 1AP
1986-10-31Type 1 - New Molecular Entity · Original · priorityAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →